2D & 3D printing technologies in pharmaceutical manufacturing – Presented by Markus Dachtler, Gen-Plus

Markus Dachtler

2D & 3D printing technologies in pharmaceutical manufacturing – Presented by Markus Dachtler, Gen-Plus at the 3D Medical Conference 2018,  which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

Personalized medicine has gained growing interest over the last decade. Printed formulations can be individually and cost-effectively manufactured down to a batch size of one. Further advantages of printed dosage forms are e.g. combination of drugs and excipients which are not compatible with traditional manufacturing techniques enabling the production of polypills with tailor-made release characteristics. Drug printing can be also used for cost-effective dose-finding studies. The presentation gives an overview of 2D & 3D drug printing technologies and recent examples of drug printing in pharmaceutical manufacturing.

About Markus Dachtler
Dr. Markus Dachtler (MBA, PMP)  studied chemistry and is working for more than 12 years in pharmaceutical industry. In 2015 he acquired Gen-Plus in Munich. Gen-Plus is a high-tech R&D lab, developing hard-to-make formulations of solid/semi-solid dosage forms as well as patches (TTS) and thin films for many customers. This includes also e.g. high potent developments, narcotics, and abuse deterrent formulations from the idea phase until IMP production for clinical trials I/II under GMP. Novel technologies include 2D/3D drug printing and e-drug delivery systems. Dr. Dachtler gives regular lectures, has authored more than 20 publications in international journals and also holds patents. In his scientific career he got several innovation awards and the Richard R. Ernst Prize in 1998. Continue reading “2D & 3D printing technologies in pharmaceutical manufacturing – Presented by Markus Dachtler, Gen-Plus”